Clinical Trial Update: A Phase II Study of Belatacept (BMS-224818) With a Steroid-free Regimen in Subjects Undergoing Kidney Transplantation [Phase 2]

View source ↗

Summary

A Phase II study of belatacept with a steroid-free regimen in kidney transplant recipients has completed, with results posted in 2013.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Transplantation

Drugs mentioned

• belatacept (belatacept)

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: Disorder Related to Renal Transplantation | Phase 2 | Status: COMPLETED | Results posted: 2013-11-21